Skip to main content
For Healthcare Professionals
Logout
boehringer_logo
Boehringer Ingelheim
boehringer_logo
Boehringer Ingelheim
boehringer_logo
Boehringer Ingelheim
  • Take a SIP
  • Logout

    Boehringer Ingelheim

    Why should medications with organ protection be initiated early for people with diabetes?

    Prof. Jennifer Green

    • Back to Home
    SIP||ASK-JARD-T2D-CAR-8||PC-PH-105868||Prof Green - PCP's role in CKD management, when to refer

    Related Videos

    Watch now
    What is the role of primary care in CKD management

    What is the role of primary care in CKD management?

    Prof Christoph Wanner
    Watch now
    Watch now
    How consistent is the renal protective benefits of Empagliflozin based on evidence

    How consistent is the renal protective benefits of Empagliflozin based on evidence?

    Prof Christoph Wanner
    Watch now
    1. Home
    2. Why should medications with organ protection be initiated early for people with diabetes? - 2025

    Sitemap

    • Therapeutic Area

      • Cardiovascular
      • Metabolic
    • Resources

      • Videos
      • Clinical studies

    • Privacy
    • Terms of use
    • Sitemap
    • Contact

    footer logo
    BI logo

    Copyright © 2025 Boehringer Ingelheim (Philippines), Inc. All rights reserved. Use of this Site is subject to the Terms of Use and Privacy Statement. Prepared June 2025